SCAI Town Hall: TAVR National Coverage Determination

How To Register

To register, press the "Log In" or "Register" button.
Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login."

Description

The Centers for Medicare & Medicaid Services (CMS) is expected to release a Proposed Decision Memo in June 2026, opening a new 30-day public comment period that could shape future policy surrounding Transcatheter Aortic Valve Replacement (TAVR) eligibility, heart team requirements, and patient access.

In this virtual town hall, SCAI leadership and public participants discuss the ongoing CMS review of the TAVR National Coverage Determination (NCD) ahead of the upcoming public comment period.

Panelists

	J. Dawn Abbott, MD, MSCAI SCAI President		John C. Messenger, MD, MSCAI SCAI Vice President
	Arnold H. Seto, MD, FSCAI SCAI Advocacy Committee Chair		George S. Hanzel, MD, FSCAI SCAI SHD Chair
	Michael N. Young, MD, FSCAI SCAI SHD Chair		Molly Szerlip, MD, FSCAI SCAI Advocacy Co-Chair
	Monica Wright, DPA, MHA, CPC, CPMA, CPCO SCAI Director of Regulatory Affairs

Continuing Education Information

This activity is not certified for accredited continuing education.

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

No Credit Offered